Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391–398; discussion 398–401 (1994)

Givi B, Pommier SJ, Thompson AK, Diggs BS, Pommier RF (2006) Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival. Surgery 140:891–897; discussion 897–898

Gupta PK et al (2011) Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation 124:381–387PubMedCrossRef

Hadi R et al (2006) Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapy. ANZ J Surg 76:156–161PubMedCrossRef

Hodul PJ, Strosberg JR, Kvols LK (2008) Aggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated? Cancer Control: J Moffitt Cancer Cent 15:314–321

Simmonds PC et al (2006) Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94:982–999PubMedCentralPubMedCrossRef

Improved survival with preoperative radiotherapy in resectable rectal cancer (1997). Swedish rectal cancer trial. N. Engl J Med 336: 980–987

Kaemmerer D et al (2009) Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic tumor. World J Gastroenterol: WJG 15:5867–5870PubMedCentralPubMedCrossRef

Kaemmerer D et al (2012) Radioguided surgery in neuroendocrine tumors using Ga-68-labeled somatostatin analogs: a pilot study. Clin Nucl Med 37:142–147PubMedCrossRef

Kang T et al (2010) Does blue dye contribute to success of sentinel node mapping for breast cancer? Ann Surg Oncol 17(Suppl 3):280–285PubMedCrossRef

Kapiteijn E et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N. Engl J Med 345:638–646PubMedCrossRef

Konstantinidis IT et al (2012) Pancreatic ductal adenocarcinoma: is there a survival difference for r1 resections versus locally advanced unresectable tumors? What is a true r0 resection?. Ann Surg

Kwekkeboom DJ et al (2008) Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0, Tyr3]octreotate: toxicity, efficacy, and survival. J Clin Oncol: Official J Am Soc Clin Oncol 26:2124–2130CrossRef

Lee TH et al (1999) Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100:1043–1049PubMedCrossRef

Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428PubMedCrossRef